SwiftDX | High Sensitivity LFT Development & Manufacture
Creating the next generation of lateral flow devices. SwiftDx’s portfolio of patented technologies enable ultra-boosted sensitivity lateral flow diagnostics for diseases which are undetectable with current lateral flow test technology. SwiftDx has successfully completed the initial technology development phase and is ready to commercialise its DNA detection and eAMP technologies. The company’s first product (the SwiftDx Mycoplasma Detection kit) has been launched and a further products are in development. Our goal is to better inform patients and healthcare practitioners with a new generation of lateral flow tests.
This company is:
Verified
Products | SwiftDx
Creating the next generation of lateral flow devices SwiftDx products Delivering Transformative Products Product development & delivery is the core of SwiftDx's mission, combining ultra-boosted sensitivity with simple point-of-care (POC) or self-testing diagnostic solutions. SwiftDx technologies allow the creation of point-of-need diagnostics for diseases where the diagnostic targets (e.g. antigen/antibodies) are otherwise not detected by
Verified
Prostate Cancer Testing | Next-Generation Testing | SwiftDx
Our mission is to produce a high-sensitivity PSA threshold diagnostic test using eAMP technology to provide early & accurate diagnosis of prostate cancer.
Verified
Dengue Fever Testing | Rapid Diagnostic Testing | SwiftDx
Dengue Fever is a serious viral infection spread by mosquitos. At SwiftDx, our mission is to produce a high-sensitivity rapid diagnostic test for Dengue Fever.
View all products
Keywords
Industries
Where is Swift Molecular Diagnostics located?
The company Swift Molecular Diagnostics is located in Cambridge, England, United Kingdom. It's worth noting that the company may has more corporate locations
How many employees does Swift Molecular Diagnostics approximately have?
As of the latest available information Swift Molecular Diagnostics has around 1-10 employees worldwide.
When was Swift Molecular Diagnostics founded?
Swift Molecular Diagnostics was founded in 2016
In which industries does Swift Molecular Diagnostics mainly work?
The company Swift Molecular Diagnostics has it's main focus in the industries of Other
Global Access Dx (GADx) (formerly Mologic)
United Kingdom
51-100 Employees
2003
View
SpeeDx
Australia
11-50 Employees
2009
View
Diaxxo AG
Switzerland
1-10 Employees
2020
View
LEX Diagnostics
United Kingdom
11-50 Employees
2020
View
Dianax
Italy
11-50 Employees
2013
View
Anavasi Diagnostics
United States
2021
View
Co-Diagnostics
United States
1-10 Employees
2013
View
Visby Medical
United States
251-500 Employees
2012
View
Topics which have been searched by others and may be interesting for you:
